ecrin-mdr-crcClinical2010Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsObservationalhttps://newmdr.ecrin.org/Study/2100791Romania3ECRIN MDRTerminatedfalseAn Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)This observational study will evaluate Xeloda (capecitabine) monotherapy on the effect of disease-free survival in patients with colon cancer stage III (Duke C) after surgical resection. Data will be collected for 3 years.2010-03-152100791NCT01276405